Suppr超能文献

β淀粉样蛋白诱导半胱天冬酶介导的P2X4裂解,以促进嘌呤毒性。

Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity.

作者信息

Varma R, Chai Y, Troncoso J, Gu J, Xing H, Stojilkovic S S, Mattson M P, Haughey N J

机构信息

Department of Neurology, Johns Hopkins, University School of Medicine, Meyer 6-109, 600 N. Wolfe St., Baltimore, MD 21287, USA.

出版信息

Neuromolecular Med. 2009;11(2):63-75. doi: 10.1007/s12017-009-8073-2. Epub 2009 Jun 27.

Abstract

Overproduction of the beta-amyloid fragment 1-42 (A beta(1-42)) is thought to contribute to synaptic dysfunction and neuronal death in Alzheimer's disease. Mounting evidence suggests that purinergic receptors play critical roles in synaptic plasticity and neuronal survival, but the potential involvement of these receptors in A beta(1-42)-induced synaptic dysfunction and neuronal death has not been addressed. Here we report that A beta(1-42) promoted accumulation of the calcium-permeable purinergic receptor P2X4 in neurons. We also report evidence that A beta(1-42) induced a caspase-3-mediated cleavage of the receptor that slowed channel closure times and prevented agonist-induced internalization of the receptor. Molecular interference to reduce the expression of P2X4 in primary rodent neurons attenuated A beta(1-42)-induced neuronal death while induced expression of P2X4 in a neuronal cell line that does not normally express P2-receptors enhanced the toxic effect of A beta(1-42). Together these findings suggest that A beta(1-42)-induced synaptic dysfunction and neuronal death may involve perturbations in P2X4 purinergic receptors.

摘要

β-淀粉样蛋白片段1-42(Aβ(1-42))的过度产生被认为与阿尔茨海默病中的突触功能障碍和神经元死亡有关。越来越多的证据表明嘌呤能受体在突触可塑性和神经元存活中起关键作用,但这些受体在Aβ(1-42)诱导的突触功能障碍和神经元死亡中的潜在参与尚未得到探讨。在此我们报告,Aβ(1-42)促进了神经元中钙通透性嘌呤能受体P2X4的积累。我们还报告了证据表明,Aβ(1-42)诱导了受体的半胱天冬酶-3介导的切割,这减缓了通道关闭时间并阻止了激动剂诱导的受体内化。在原代啮齿动物神经元中减少P2X4表达的分子干扰减弱了Aβ(1-42)诱导的神经元死亡,而在通常不表达P2受体的神经元细胞系中诱导P2X4表达则增强了Aβ(1-42)的毒性作用。这些发现共同表明,Aβ(1-42)诱导的突触功能障碍和神经元死亡可能涉及P2X4嘌呤能受体的扰动。

相似文献

1
Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity.
Neuromolecular Med. 2009;11(2):63-75. doi: 10.1007/s12017-009-8073-2. Epub 2009 Jun 27.
2
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
Nature. 2009 Feb 26;457(7233):1128-32. doi: 10.1038/nature07761.
3
Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease.
J Neurosci. 2010 May 19;30(20):6873-81. doi: 10.1523/JNEUROSCI.0519-10.2010.
4
Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease.
Neuroreport. 2008 Nov 19;19(17):1715-9. doi: 10.1097/WNR.0b013e3283179333.
9
P2X receptor trafficking in neurons is subunit specific.
J Neurosci. 2002 Jun 15;22(12):4814-24. doi: 10.1523/JNEUROSCI.22-12-04814.2002.

引用本文的文献

1
Species Differences of P2X4 Receptor Modulators.
ACS Pharmacol Transl Sci. 2025 Jan 30;8(5):1320-1332. doi: 10.1021/acsptsci.4c00688. eCollection 2025 May 9.
2
Microglial purinergic signaling in Alzheimer's disease.
Purinergic Signal. 2024 Jun 24. doi: 10.1007/s11302-024-10029-8.
3
Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.
Purinergic Signal. 2024 Dec;20(6):645-656. doi: 10.1007/s11302-024-10005-2. Epub 2024 May 25.
4
Implications of COVID-19 in Parkinson's disease: the purinergic system in a therapeutic-target perspective to diminish neurodegeneration.
Purinergic Signal. 2024 Oct;20(5):487-507. doi: 10.1007/s11302-024-09998-7. Epub 2024 Mar 9.
8
Triggering of Major Brain Disorders by Protons and ATP: The Role of ASICs and P2X Receptors.
Neurosci Bull. 2023 May;39(5):845-862. doi: 10.1007/s12264-022-00986-8. Epub 2022 Nov 29.
10
Microglial Activation Modulated by P2X4R in Ischemia and Repercussions in Alzheimer's Disease.
Front Physiol. 2022 Feb 23;13:814999. doi: 10.3389/fphys.2022.814999. eCollection 2022.

本文引用的文献

2
Altered hippocampal synaptic potentiation in P2X4 knock-out mice.
J Neurosci. 2006 Aug 30;26(35):9006-9. doi: 10.1523/JNEUROSCI.2370-06.2006.
3
A C-terminal lysine that controls human P2X4 receptor desensitization.
J Biol Chem. 2006 Jun 2;281(22):15044-9. doi: 10.1074/jbc.M600442200. Epub 2006 Mar 13.
4
Calcium in Alzheimer's disease pathogenesis: too much, too little or in the wrong place?
J Alzheimers Dis. 2005 Nov;8(2):147-54; discussion 209-15. doi: 10.3233/jad-2005-8207.
6
Spinal cord injury induces early and persistent lesional P2X4 receptor expression.
J Neuroimmunol. 2005 Jun;163(1-2):185-9. doi: 10.1016/j.jneuroim.2005.02.016. Epub 2005 Apr 26.
7
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.
Cell. 2005 Feb 25;120(4):545-55. doi: 10.1016/j.cell.2005.02.008.
8
Molecular determinants of the agonist binding domain of a P2X receptor channel.
Mol Pharmacol. 2005 Apr;67(4):1078-88. doi: 10.1124/mol.104.010108. Epub 2005 Jan 4.
9
Cellular distribution and functions of P2 receptor subtypes in different systems.
Int Rev Cytol. 2004;240:31-304. doi: 10.1016/S0074-7696(04)40002-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验